HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference75 articles.
1. Head and neck cancer;Lancet,2021
2. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics;Cancer Cell,2014
3. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts;Nature,1981
4. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene;Science,1985
5. Cell signaling by receptor tyrosine kinases;Cell,2010
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic and Predictive Roles of HER2 Status in Non-Breast and Non-Gastroesophageal Carcinomas;Cancers;2024-09-13
2. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review;Frontiers in Oncology;2024-08-22
3. Head and neck cancer: pathogenesis and targeted therapy;MedComm;2024-08-21
4. In Vivo Combined Photoacoustic Imaging and Photothermal Treatment of HPV‐Negative Head and Neck Carcinoma with NIR‐Responsive Non‐Persistent Plasmon Nano‐Architectures;Advanced Therapeutics;2024-06-06
5. Treatment Response of Gingival Squamous-Cell Carcinoma to Palliative Intent Immunotherapy;Current Oncology;2023-12-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3